BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 2414505)

  • 1. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors.
    Uchida A; Klein E
    Immunol Lett; 1985; 10(3-4):177-81. PubMed ID: 3899922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural cytotoxicity of human blood monocytes: production of monocyte cytotoxic factors (MCF) during interaction with tumor cells.
    Uchida A; Yanagawa E
    Immunol Lett; 1984; 8(6):311-6. PubMed ID: 6597126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in NK resistance induced by interferon-gamma.
    Ramirez R; Solana R; Carracedo J; Alonso MC; Peña J
    Cell Immunol; 1992 Mar; 140(1):248-56. PubMed ID: 1739986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
    Sibbitt WL; Mathews PM; Bankhurst AD
    Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
    Roozemond RC; Mevissen M; Urli DC; Bonavida B
    J Immunol; 1987 Sep; 139(5):1739-46. PubMed ID: 3624869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of human natural killer cytotoxic factor (NKCF): characterization and analysis of its mode of action.
    Ortaldo JR; Blanca I; Herberman RB
    Adv Exp Med Biol; 1985; 184():203-20. PubMed ID: 3898750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of X-ray irradiation on natural killer (NK) cell system. II. Increased sensitivity to natural killer cytotoxic factor (NKCF).
    Uchida A; Mizutani Y; Nagamuta M; Ikenaga M
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):521-34. PubMed ID: 2621326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Agostini C; Chisesi T; Vespignani M; Pizzolo G; Pandolfi F; Ensoli F; Semenzato G
    Leuk Res; 1989; 13(4):315-22. PubMed ID: 2497276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.